4.6 Article

Gestational Hypothyroxinemia Affects Glutamatergic Synaptic Protein Distribution and Neuronal Plasticity Through Neuron-Astrocyte Interplay

期刊

MOLECULAR NEUROBIOLOGY
卷 53, 期 10, 页码 7158-7169

出版社

SPRINGER
DOI: 10.1007/s12035-015-9609-0

关键词

Gestational hypothyroxinemia; Glutamatergic synapse; Astrocyte; Neuron

资金

  1. Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile (FONDECYT) [1130996, 1140010, 1110604, 1100971, 1131012, 1110397]
  2. Millennium Institute on Immunology and Immunotherapy [P09/016-F]
  3. La Region Pays De La Loire through the Nouvelles Equipes-nouvelles thematiques Grant
  4. Comite de Evaluacion y Orientacion de la Cooperacion Cientifica con Chile del Gobierno de Francia (ECOS) [C11S03]
  5. Universidad Andres Bello (UNAB) [Inicio DI-31/11R, Nucleo UNAB DI-471-15/N]

向作者/读者索取更多资源

Gestational hypothyroxinemia, characterized by low levels of maternal thyroxine (T-4) during gestation, is closely associated with cognitive impairment in offspring. Studies in animal models have shown that this condition alters neuronal glutamatergic synapses in the hippocampus. Given that astrocytes critically contribute to the establishment and functioning of synapses, the aim of this study was to determine the effects of gestational hypothyroxinemia on the capacity of astrocytes to regulate glutamatergic synapses. In an in vitro co-culture model of astrocytes and hippocampal neurons, gestational hypothyroxinemia profoundly affected the synaptic patterns of GluN1 and CD3 zeta in an astrocyte-dependent manner. These effects were associated with impaired plasticity that was dependent on both neuronal and astrocyte contributions. These results highlight the importance of neuron-astrocyte interplay in the deleterious effects of gestational hypothyroxinemia and the timely diagnosis and treatment of this condition during gestation to ensure proper central nervous system development in offspring.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

Katia Abarca, Carolina Iturriaga, Marcela Urzua, Nicole Le Corre, Augusto Pineda, Carolina Fernandez, Angelica Dominguez, Pablo A. Gonzalez, Susan M. Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela Gonzalez, Paula Guzman, Paula Munoz-Venturelli, Carlos M. Perez, Marcela Potin, Alvaro Rojas, Jose Gonzalez-Aramundiz, Nicolas M. S. Galvez, Francisca Aguirre-Boza, Sofia Aljaro, Luis Federico Batiz, Yessica Campisto, Mariela Cepeda, Aaron Cortes, Sofia Lopez, Maria Loreto Perez, Andrea Schilling, Alexis M. Kalergis

Summary: This study investigated the safety and effectiveness of two different immunization schedules of CoronaVac(R) in healthy adults. The results showed that CoronaVac(R) vaccine is safe and effective in preventing severe cases of COVID-19. There were no significant differences in adverse events between the two schedules, and both schedules provided protection against COVID-19 hospitalization.

VACCINES (2022)

Article Biochemistry & Molecular Biology

Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection

Gisela Canedo-Marroquin, Jorge A. Soto, Catalina A. Andrade, Susan M. Bueno, Alexis M. Kalergis

Summary: The human respiratory syncytial virus (hRSV) can impair pulmonary immune surveillance mechanisms and promote secondary mycobacterial colonization. Immunization can modulate the expression of HO-1 on immune and epithelial cells, which may contribute to the repair of pulmonary tissue.

ANTIOXIDANTS (2022)

Article Immunology

Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections

Pablo J. Bertrand, Yaneisi Vazquez, Andrea A. Beckhaus, Liliana A. Gonzalez, Ana Maria Contreras, Marcela Ferres, Oslando Padilla, Claudia A. Riedel, Alexis M. Kalergis, Susan M. Bueno

Summary: The study suggests that IL-8 and IL-33 are significantly increased in lower respiratory tract infections caused by RSV and could be potential biomarkers for clinical severity in children with LRTIs.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2022)

Review Pharmacology & Pharmacy

From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection

J. A. Soto, N. M. S. Galvez, D. B. Rivera, F. E. Diaz, C. A. Riedel, S. M. Bueno, A. M. Kalergis

Summary: This article highlights the importance of choosing the appropriate animal models to evaluate the effectiveness of antiviral drugs, vaccine prototypes, and pharmacological molecules in protecting against hRSV.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Review Biochemistry & Molecular Biology

Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus

Jorge A. Soto, Felipe Melo-Gonzalez, Claudia A. Riedel, Susan M. Bueno, Alexis M. Kalergis

Summary: CLE is an autoimmune disorder characterized by autoantibody secretion and immune cell recruitment, similar to SLE. It can be divided into different types with varying severity of skin lesions. Type I IFN plays a significant role in the development of CLE. Research aims to develop effective treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Immunology

Is there a role for herpes simplex virus type 1 in multiple sclerosis?

Luisa F. Duarte, Sebastian Gatica, Almendra Castillo, Alexis M. Kalergis, Susan M. Bueno, Claudia A. Riedel, Pablo A. Gonzalez

Summary: Numerous studies have linked the onset and severity of multiple sclerosis (MS) with viral infections. Herpes simplex virus type 1 (HSV-1), which is neurotropic and commonly found in the brains of healthy individuals, has been suggested to be associated with MS. This review discusses the reported connections between HSV-1 and MS.

MICROBES AND INFECTION (2023)

Review Virology

LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections

Linmar Rodriguez-Guilarte, Mario A. Ramirez, Catalina A. Andrade, Alexis M. Kalergis

Summary: LAG-3 is an inhibitory receptor expressed on immune cells, which regulates T cell activation and effector functions in the immune response. Immunotherapies targeting immune checkpoints, including LAG-3, have shown promise in controlling malignant tumors and chronic viral diseases.

VIRUSES-BASEL (2023)

Article Biochemistry & Molecular Biology

Heme Oxygenase-1 Expression in Dendritic Cells Contributes to Protective Immunity against Herpes Simplex Virus Skin Infection

Eduardo I. Tognarelli, Luisa F. Duarte, Monica A. Farias, Felipe A. Cancino, Nicolas Corrales, Francisco J. Ibanez, Claudia A. Riedel, Susan M. Bueno, Alexis M. Kalergis, Pablo A. Gonzalez

Summary: Stimulating HO-1 expression in HSV-infected dendritic cells can promote cell viability and inhibit viral egress. It also promotes the expression of anti-inflammatory molecules and activation of virus-specific CD4(+) T cells. Transferring HSV-infected dendritic cells with induced HO-1 expression can enhance virus-specific T cell activation and improve the outcome of HSV-1 skin infection.

ANTIOXIDANTS (2023)

Article Immunology

Differential Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Response in Inactivated Virus-Vaccinated, Convalescent, and Breakthrough-Infected Subjects

Luisa F. Duarte, Yaneisi Vazquez, Benjamin Diethelm-Varela, Valentina Pavez, Roslye Berrios-Rojas, Claudia A. Riedel, Constanza Mendez, Jessica A. White, Alexis M. Kalergis, Susan M. Bueno, Pablo A. Gonzalez

Summary: This study aimed to identify potential antigens for distinguishing humoral responses after vaccination with CoronaVac, natural infection, or breakthrough infection. The results showed that CoronaVac vaccination induced higher levels of antibodies against the viral membrane protein, while the levels of IgG antibodies against the nucleocapsid protein were similar between the booster dose group and convalescent subjects. Breakthrough case patients had the highest antibody levels against the N and M proteins.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Immunology

Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study

Sebastian Mondaca, Benjamin Walbaum, Nicole Le Corre, Marcela Ferres, Alejandro Valdes, Constanza Martinez-Valdebenito, Cinthya Ruiz-Tagle, Patricia Macanas-Pirard, Patricio Ross, Betzabe Cisternas, Patricia Perez, Olivia Cabrera, Valentina Cerda, Ivana Ormazabal, Aldo Barrera, Maria E. Prado, Maria I. Venegas, Silvia Palma, Richard Broekhuizen, Alexis M. Kalergis, Susan M. Bueno, Manuel A. Espinoza, M. Elvira Balcells, Bruno Nervi

Summary: Cancer patients receiving chemotherapy treatment have a lower immune response to SARS-CoV-2 vaccines. Our study demonstrated that booster vaccines elicit strong humoral and cellular responses among cancer patients receiving chemotherapy, regardless of the type of vaccine used as a priming dose. The homologous vaccine regimen was associated with higher neutralizing antibody positivity and total antibody levels.

VACCINES (2023)

Review Microbiology

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines

Xanthippi Topalidou, Alexis M. Kalergis, Georgios Papazisis

Summary: RSV is a significant cause of morbidity and mortality in young children and older adults. The development of RSV vaccines is guided by epidemiologic and pathophysiological evidence, using various vaccine technologies. Currently, there are 24 vaccines in clinical development, including two licensed vaccines.

PATHOGENS (2023)

暂无数据